Pramipexol-Mepha ER 0.375 mg

Pramipexol-Mepha ER 0.375 mg is a medicine authorised by Swissmedic under authorisation number 65797. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 August 2016 and the authorisation is valid without a time limit. ATC code N04BC05 places the medicine in the group Anti-Parkinson drugs.

  • Dispensing category B
  • Authorisation number 65797
  • ATC N04BC05
  • Synthetic medicines
Authorisation data
Authorisation number65797
NamePramipexol-Mepha ER 0.375 mg
Full namePramipexol-Mepha ER 0.375 mg, Depotabs
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN04BC05
First authorisation09 August 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Pramipexol-Mepha ER 0.375 mg, DepotabsB09 August 2016
2Pramipexol-Mepha ER 0.75 mg, DepotabsB09 August 2016
3Pramipexol-Mepha ER 1.5 mg, DepotabsB09 August 2016
4Pramipexol-Mepha ER 3 mg, DepotabsB09 August 2016
5Pramipexol-Mepha ER 4.5 mg, DepotabsB09 August 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110Tablette(n)N04BC0501.08.0.B
210Tablette(n)N04BC0501.08.0.B
330Tablette(n)N04BC0501.08.0.B
430Tablette(n)N04BC0501.08.0.B
530Tablette(n)N04BC0501.08.0.B
630Tablette(n)N04BC0501.08.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Pramipexol-Mepha ER 0.375 mg authorised in Switzerland?

Yes. Pramipexol-Mepha ER 0.375 mg is authorised by Swissmedic under authorisation number 65797, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Pramipexol-Mepha ER 0.375 mg have?

Pramipexol-Mepha ER 0.375 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Pramipexol-Mepha ER 0.375 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com